Medicared For All Logo

Michael Raybould in N Kansas City, Missouri

Home Missouri N Kansas City

Michael Raybould has Internal Medicine as his primary medical specialty. Their primary office is: 2700 Clay Edwards Dr in N Kansas City, Missouri.

They're a part of the: Meritas Health Corporation medical group which has around 349 members. You can call their office at 816-421-4240 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Creighton University School Of Medicine and graduated in 1980 (around 44 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Michael Ward Raybould Office Phone and Directions

Michael Raybould
Meritas Health Corporation
2700 Clay Edwards Dr
N Kansas City, Missouri 64116
816-421-4240

Patient Ratings
Please rate your experience with Michael Raybould below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 816-421-4240


Enter a starting address:


Healthcare Info for Michael Raybould

Medical School: Creighton University School Of Medicine
Graduation Year: 1980
The Primary Medical Specialty for Michael Raybould is listed as: Internal Medicine
Approximate Years of Experience: 44
PAC (PECOS ID)#: 9436289741
NPI #: 1083686273
NPI Created On: 02/02/2006
NPI Last Updated Listed as: 10/24/2007
Primary Taxonomy Code: 207R00000X
License Number:
MDR7B71
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medica Insurance Company
  • Celtic Insurance Company
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

  1. Aspiration and/or injection of large joint or joint capsule
  2. X-ray of chest, 2 views
  3. Hemoglobin a1c level
  4. Blood test, clotting time
  5. Vaccine for influenza for injection into muscle
  6. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
  7. Routine ekg using at least 12 leads including interpretation and report
  8. Anti-clotting management for patient taking warfarin
  9. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  10. New patient office or other outpatient visit, typically 60 minutes
  11. Established patient office or other outpatient visit, typically 15 minutes
  12. Established patient office or other outpatient, visit typically 25 minutes
  13. Established patient office or other outpatient, visit typically 40 minutes
  14. Initial hospital inpatient care, typically 70 minutes per day
  15. Subsequent hospital inpatient care, typically 15 minutes per day
  16. Subsequent hospital inpatient care, typically 25 minutes per day
  17. Hospital discharge day management, more than 30 minutes
  18. Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge
  19. Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge
  20. Administration of influenza virus vaccine

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787681023

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787681033

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795789061

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ENDOCRINOLOGY

Name of Drug #1: CREON

Open Associated Drug #1: 0032-3016-13

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795789065

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: UBRELVY

Open Associated Drug #1: 0023-6501-10

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795789069

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: GASTROENTEROLOGY

Name of Drug #1: LINZESS

Open Associated Drug #1: 0456-1201-30

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795789073

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ENDOCRINOLOGY

Name of Drug #1: CREON

Open Associated Drug #1: 0032-3016-13

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795789077

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: QULIPTA

Open Associated Drug #1: 0074-7094-30

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795789081

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: QULIPTA

Open Associated Drug #1: 0074-7094-30

Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795789085

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: UBRELVY

Open Associated Drug #1: 0023-6501-10

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795789089

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: UBRELVY

Open Associated Drug #1: 0023-6501-10

Internal Medicine Professionals in N Kansas City

1.
Thomas Labruzzo MD

2700 Clay Edwards Dr
N-kansas-city, MO
Meritas Health Corporation

2.
Varaporn Treemaneekarn

2700 Clay Edwards Dr
N-kansas-city, MO
Meritas Health Corporation

3.
Samin Akhtar MD

2700 Clay Edwards Dr
N-kansas-city, MO
Meritas Health Corporation

4.
Crystal Lagalle

2700 Clay Edwards Dr
N-kansas-city, MO
Meritas Health Corporation

5.
Magnus Nwora

2700 Clay Edwards Dr
N-kansas-city, MO
Meritas Health Corporation

6.
Stephanie Swords DO

2700 Clay Edwards Dr
N-kansas-city, MO
Meritas Health Corporation

Providers in Meritas Health Corporation

1.Avery Abernathy

6450 N Chatham Ave
Kansas City Mo 64151-2403
Meritas Health Corporation
Family Practice

2.Antonette Acosta-dickson Md

2800 Clay Edwards Dr
North Kansas City Mo 64116-3220
Meritas Health Corporation
Family Practice

3.Antonette Acosta-dickson Md

6450 N Chatham Ave
Kansas City Mo 64151-2403
Meritas Health Corporation
Family Practice

4.Samin Akhtar Md

2700 Clay Edwards Dr
N Kansas City Mo 64116-3270
Meritas Health Corporation
Internal Medicine

5.Drew Allen

2790 Clay Edwards Dr
North Kansas City Mo 64116-3274
Meritas Health Corporation
Cardiovascular Disease (cardiology)

6.Drew Allen

9411 N Oak Trafficway
Kansas City Mo 64155-2281
Meritas Health Corporation
Cardiovascular Disease (cardiology)

View all 349 members of Meritas Health Corporation medical group


Medicared For All
Vote!
Share